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Dysregulated immune responses to commensal intestinal bacteria, including Escherichia coli, contribute to the development of
inflammatory bowel diseases (IBDs) and experimental colitis. Reciprocally, E. coli responds to chronic intestinal inflammation
by upregulating expression of stress response genes, including gadA and gadB. GadAB encode glutamate decarboxylase and pro-
tect E. coli from the toxic effects of low pH and fermentation acids, factors present in the intestinal lumen in patients with active
IBDs. We hypothesized that E. coli upregulates gadAB during inflammation to enhance its survival and virulence. Using real-
time PCR, we determined gadAB expression in luminal E. coli from ex-germfree wild-type (WT) and interleukin-10 (IL-10)
knockout (KO) (IL-10/) mice selectively colonized with a commensal E. coli isolate (NC101) that causes colitis in KO mice in
isolation or in combination with 7 other commensal intestinal bacterial strains. E. coli survival and host inflammatory responses
were measured in WT and KO mice colonized with NC101 or a mutant lacking the gadAB genes (NC101gadAB). The suscepti-
bility of NC101 and NC101gadAB to killing by host antimicrobial peptides and their translocation across intestinal epithelial
cells were evaluated using bacterial killing assays and transwell experiments, respectively. We show that expression of gadAB in
luminal E. coli increases proportionately with intestinal inflammation in KO mice and enhances the susceptibility of NC101 to
killing by the host antimicrobial peptide cryptdin-4 but decreases bacterial transmigration across intestinal epithelial cells, co-
lonic inflammation, and mucosal immune responses. Chronic intestinal inflammation upregulates acid tolerance pathways in
commensal E. coli isolates, which, contrary to our original hypothesis, limits their survival and colitogenic potential. Further
investigation of microbial adaptation to immune-mediated inflammation may provide novel insights into the pathogenesis and
treatment of IBDs.
The human gastrointestinal tract is home to a complex commu-nity of microbes whose number exceeds the number of host
cells by over an order of magnitude (1). In the healthy state, pro-
tective host mechanisms, including bacterium-induced regula-
tory T cells and rapid microbial adaptation, result in a dynamic
equilibrium between the intestinal immune system and this large
number of microbial symbionts (2, 3). However, mounting evi-
dence suggests that members of the intestinal microbiota, includ-
ing adherent-invasive strains of Escherichia coli, also induce mal-
adaptive immune responses in patients with inflammatory bowel
diseases (IBDs) (4). Currently, the prevailing hypothesis is that a
subset of commensal enteric bacteria provides antigenic stimula-
tion that continuously activates pathogenic T cells to cause
chronic intestinal injury (5). Similar to human IBDs, the impor-
tance of the intestinal microbiota in the pathogenesis of chronic,
immune-mediated experimental colitis is evident in gnotobiotic
studies using animals with immunoregulatory defects, including
the interleukin-10 (IL-10)-deficient (IL-10/) mouse. In this
model, development of chronic intestinal inflammation requires
the presence of commensal microbes (6, 7). Moreover, selective
colonization (monoassociation) of IL-10/ mice with defined
commensal bacteria, including adherent-invasive E. coli, causes
colitis (7–10).
While the influence of the microbiota on host immune re-
sponses has been extensively studied, little is known about the
effects of inflamed intestine on bacterial properties that may per-
petuate the cycle of mucosal inflammation. Host inflammatory
responses enhance the virulence of certain enteric pathogens (11–
13), and we recently reported that colitis in E. coli-monoassociated
IL-10/ mice over a long period induces upregulation of stress-
response genes, including gadA and gadB, in commensal luminal
E. coli (14).
Although the gadA and gadB genes are not located in the same
operon, their function appears to be redundant. gadA and gadB
(gadAB) encode glutamate decarboxylase proteins that are part of
the glutamate-dependent acid resistance system 2 (AR2) in E. coli,
which protects the bacteria from acid conditions (pH 2.5 to 4.5),
including those encountered during passage through the stomach
into the intestine (15, 16). While the roles of E. coli GadAB in
bacterial survival during transit through the normal gastrointes-
tinal tract have been described (15, 17), little is known about the
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effect of these proteins on E. coli viability in the inflamed gut and
how they affect host immune responses.
Since active IBDs are variably associated with decreased lumi-
nal pH (18) and increased colonic levels of some fermentation
acids (19, 20) and because gadAB protect E. coli from the toxic
effects of low pH and fermentation acids (16, 21), we hypothesized
that E. coli upregulates gadAB in the inflamed colon in order to
survive and perpetuate colitis. In the present study, we show that,
contrary to our hypothesis, expression of gadAB in luminal com-
mensal E. coli is associated with reduced bacterial survival and
attenuated colitis, which may be due in part to increased suscep-
tibility to bacterial killing by host antimicrobial peptides (AMPs)
and decreased translocation across intestinal epithelial cells. These
results suggest that inflammation-associated changes in commen-
sal bacterial gene expression may paradoxically decrease luminal
bacterial survival and attenuate the host inflammatory response.
MATERIALS AND METHODS
Bacterial strains, lysates, and growth curves. The nonpathogenic murine
E. coli strain NC101 was isolated as described previously (8). The Entero-
coccus faecalis human oral isolate (strain OG1RF) was provided by Mark
Huycke. Mutant strain NC101gadAB was constructed using the bacte-
riophage -red recombinase method (22). Mutant strains NC101gadAB
attTn7::gadBA and NC101gadAB(pgadB) were generated using stan-
dard molecular biology techniques (see the methods in the supplemental
material). Bacterial lysates were prepared and bacterial growth curves
were generated as described previously (8, 14). In separate experiments,
germfree mice were colonized by oral gavage with a mixture of Enterococ-
cus faecalis OG1RF, Bacteroides thetaiotaomicron VPI-5482, Bacteroides
vulgatus ATCC 8482, Bifidobacterium longum subsp. infantis ATCC
15697, Lactobacillus rhamnosus GG, Ruminococcus gnavus ATCC 29149,
Faecalibacterium prausnitzii A2-165, and either E. coli NC101 or E. coli
NC101gadAB that had been cultured anaerobically overnight.
Antimicrobial peptide bacterial killing assays. Bacteria were grown
to mid-exponential phase and washed in 10 mM PIPES buffer, pH 7.3,
and the optical density at 600 nm was adjusted to 1.0 using PIPES
[piperazine-N,N=-bis(2-ethanesulfonic acid)] containing 1% LB. Bacte-
rial suspensions were incubated with either medium control (PIPES plus
1% LB) or recombinant murine cryptdin-4 (a gift from Andrew Oulette)
for 1 h, after which viable bacteria were enumerated by plating serial
dilutions.
Mice. Germfree (GF) IL-10/ and wild-type (WT) controls (both on
the 129S6/SvEV background) were originally derived under sterile condi-
tions by hysterectomy at the Gnotobiotic Laboratory (University of Wis-
consin, Madison). Mice maintained under GF conditions at the National
Gnotobiotic Rodent Resource Center at the University of North Carolina
(UNC)—Chapel Hill were monoassociated with bacteria by swabbing the
mouth and anus with an overnight bacterial culture of E. coli NC101 or
NC101gadAB. The absence of isolator contamination was confirmed by
Gram stain and culture of cecal contents on brain heart infusion (BHI)
agar plates under aerobic and anaerobic conditions. All animal protocols
were approved by the UNC—Chapel Hill Institutional Animal Care and
Use Committee.
RNA isolation from cecal contents. Freshly harvested cecal or midco-
lonic contents (100 to 300 mg) were snap-frozen in liquid N2 and stored at
80°C. Frozen samples were thawed into 1 ml of Qiagen RNAprotect
bacterial reagent while vortexing and incubated at 25°C for 5 min, and
bacterial RNA was isolated as described previously (23).
Extraction of DNA from colon tissue. Bacterial DNA was isolated
from snap-frozen cecal tissue using phenol-chloroform extraction, phys-
ical disruption, and DNA purification on Qiagen DNeasy blood and tissue
columns (see the methods in the supplemental material).
Real-time PCR. Real-time oligonucleotide primers were designed us-
ing either Primer 3 or Applied Biosystems Primer Express (version 3.0)
software based on E. coli NC101 genomic DNA sequences published in
GenBank (see Table S1 in the supplemental material). First-strand cDNA
was synthesized, and quantitative real-time PCRs were performed as de-
scribed previously (14), except that Bio-Rad 2 iTaq SYBR green PCR
Supermix was used. To quantify the number of E. coli 16S rRNA gene
copies in cecal tissue, 50 ng of tissue DNA was added to each real-time
PCR mixture and the results were normalized to those for murine
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) using the CT
(where CT is the threshold cycle) method.
Quantification of luminal bacteria. Luminal E. coli concentrations in
monoassociated mice were measured by dilution plating on BHI agar as
described previously (14). Cecal E. coli concentrations in animals with
bacterial octoassociation (animals colonized with the mixture of the seven
commensal strains representative of the normal gut microbiota indicated
above plus an E. coli strain) were measured by quantitative PCR of the E.
coli 16S rRNA gene as described above, but using bacterial genomic DNA
isolated from cecal contents rather than cecal tissue. Absolute quantifica-
tion of E. coli genome copies per ng of total DNA was performed using a
standard curve generated from purified E. coli genomic DNA, assuming
that the E. coli NC101 genome is 5.02 Mb and contains 7 copies of the 16S
rRNA gene.
Histological scoring. Composite histological inflammation scores of
colon tissue were determined as described previously (14).
Immunofluorescence staining. To detect E. coli in intestinal tissue,
paraffin-embedded intestinal sections were rehydrated in a xylene-alco-
hol gradient, permeabilized with phosphate-buffered saline (PBS)– 0.1%
Triton X-100 for 10 min at 25°C, blocked with PBS–5% bovine serum
albumin–1% Triton X-100, and incubated in a 1:50 dilution of biotinyl-
ated rabbit anti-E. coli polyclonal antibody (Fitzgerald Industries) for 1 h
at 25°C, followed by a 1:400 dilution of streptavidin-phycoerythrin (BD
Biosciences) for 1 h. Three images per tissue section were acquired from
randomly chosen areas using an Olympus IX71 fluorescence microscope.
In a blinded fashion, apical epithelial cell-associated bacteria per 20-
magnification field were enumerated in each image, and the numbers
from six individual intestinal sections (ileum; 2 sections of the cecum; and
the proximal, mid-, and distal colon) were summed for each animal.
Colonic tissue fragment and MLN cultures. Colonic tissue frag-
ment cultures and IL-12/23p40 enzyme-linked immunosorbent assays
(ELISAs) were performed as described previously (7, 14). Multiplex im-
munoassays for gamma interferon (IFN-), IL-1, IL-6, IL-13, IL-17,
monocyte chemoattractant protein 1, and tumor necrosis factor alpha
(TNF-) were performed using a Milliplex system (EMD Millipore) on
undiluted colon tissue fragment culture supernatants according to the
manufacturer’s instructions. For mesenteric lymph node (MLN) cultures,
single-cell suspensions of MLNs were stimulated with medium or bacte-
rial lysates, after which the IFN- in the culture supernatants was mea-
sured by ELISA as described previously (14).
T84 cell cultures and transwell experiments. The human T84 colo-
rectal cancer cell line was provided by Scott Plevy. T84 cells (2.5  105) in
high-glucose Dulbecco modified Eagle medium containing 10% fetal bo-
vine serum were cultured in the upper chamber of 12-well transwell plates
with a 3-	m pore size (Corning Costar) for 10 to 14 days, at which point
tight junctions formed and transepithelial electrical resistance was 3,500

 for 1 day, as measured with an EVOM2 ohmmeter and an Endohm-12
device. Bacteria (8  107) were added in the upper chamber and incu-
bated at either 37°C or 4°C. At the indicated times, viable bacteria in the
lower chamber were quantified by plating on LB agar. To enumerate
epithelial cell-associated bacteria, monolayers were washed 5 times with
PBS and lysed with 1% Triton X-100 for 10 min, and dilutions were plated
on LB agar. For confocal imaging, monolayers infected for 5 h were fixed
in 4% paraformaldehyde, washed, stained with anti-E. coli antibody as
described above but without permeabilization, counterstained with DAPI
(4=,6-diamidino-2-phenylindole), and visualized on a Zeiss LSM710 con-
focal microscope.
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Gentamicin protection assays. T84 cells were cultured and infected
with E. coli as described above. Monolayers were washed 3 times with PBS,
treated with gentamicin (100 	g/ml) at 37°C for 15 min, followed by 4°C
for 2 h, and washed 3 times with PBS. Epithelial cells were lysed as de-
scribed above, and intracellular bacteria were enumerated by plating di-
lutions on LB agar.
Statistical analysis. All data are presented as the mean  standard
error of the mean (SEM). P values were calculated using the unpaired,
2-tailed Student’s t test.
RESULTS
Expression of gadA and gadB is upregulated in luminal com-
mensal E. coli during intestinal inflammation. We have previ-
ously shown that E. coli stress response genes, including gadAB,
are upregulated in cecal bacteria from IL-10/ mice with colitis
monoassociated with E. coli for 7 weeks compared to their expres-
sion in healthy WT controls (14). However, whether increased
E. coli gadAB expression is the direct result of IL-10 deficiency
or colitis is unknown, nor are the kinetics of gadAB expression
during the development of colitis. To test this, we monoassoci-
ated germfree (GF) WT and IL-10/ mice for 5 days to 10 weeks
with a commensal murine strain of E. coli (NC101) that has pre-
viously been shown to induce colitis in IL-10/ mice (8). Con-
sistent with previous results, we observed a time-dependent in-
crease in histological colonic inflammation in IL-10/ but not
WT mice (Fig. 1A). Similar to the colitis scores, gadAB expression
in cecal NC101 bacteria from IL-10/ mice increased over time
and was significantly higher than that in cecal NC101 bacteria
from WT mice at later time points, when colitis was the most
severe. Surprisingly, we observed higher expression of gadAB in
cecal NC101 bacteria from healthy WT mice than IL-10/ mice
at 5 and 14 days (Fig. 1B and C). These data suggest that multiple
factors govern gadAB expression in luminal E. coli in a time-de-
pendent fashion. During early phases of colonization, non-in-
flammation-dependent factors predominate, whereas in later
phases, inflammation-related factors are paramount.
Expression of gadAB enhances susceptibility of E. coli to kill-
ing by the host -defensin cryptdin-4 in vitro and is associated
with decreased bacterial survival in vivo. Based on our hypoth-
esis that E. coli upregulates gadAB as a survival strategy, we
predicted that a mutant strain of NC101 that lacks gadAB
(NC101gadAB) would be less viable in the inflamed intestine.
In contrast, we observed significantly higher concentrations of
NC101gadAB bacteria than NC101 bacteria in cecal and colonic
luminal contents from both WT and IL-10/ monoassociated
mice (Fig. 2A; see Fig. S1 in the supplemental material). The dif-
ferences in bacterial viability in the cecum and colon are likely due
to the unique environment of these locations, since the growth of
NC101gadAB was virtually identical to that of NC101 in vitro
(Fig. 2B). The absence of gadAB expression in cecal bacteria from
mice monoassociated with NC101gadAB was confirmed by real-
time PCR (see Fig. S2 in the supplemental material). These data
demonstrate that, contrary to our original hypothesis, expression
of gadAB in E. coli impairs luminal bacterial growth in vivo but not
in vitro.
Host antimicrobial peptides (AMPs), including -defensins,
are secreted into the intestinal lumen, where they limit the growth
of certain pathogenic and commensal bacteria. The antimicrobial
activity of some AMPs depends in part on a normal proton motive
force across the bacterial inner membrane (24–26). Since GadAB
help maintain the normal proton gradient in acidic environments
(15, 16), we reasoned that expression of gadAB increases the sus-
ceptibility of NC101 to killing by AMPs. To test this hypothesis,
we treated mid-log-phase NC101 and NC101gadAB with in-
creasing concentrations of the recombinant murine -defensin
cryptdin-4 and found that NC101gadAB was more resistant
to cryptdin-4-mediated killing than NC101 at all concentrations
of cryptdin-4 tested (Fig. 2C). Complementation of NC101gadAB
with chromosomal copies of gadAB partially reversed the phenotype
(Fig. 2C). These results indicate that expression of gadAB enhances
the susceptibility of NC101 to killing by cryptdin-4 in vitro, but not
FIG 1 Expression of gadAB is upregulated in luminal E. coli during inflam-
mation. WT and IL-10/ mice were monoassociated with E. coli NC101 for 5,
14, 35, and 70 days, after which colonic histological inflammation (A) and
expression of gadA (B) and gadB (C) normalized to that of the 16S rRNA gene
in cecal NC101 were determined. Data are presented as the mean  SEM (n 
4 to 8 mice per group). *, P  0.05 relative to WT; **, P  0.01 relative to WT.
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necessarily in vivo. However, they suggest the possibility that the
decreased luminal bacterial concentrations in NC101- versus
NC101gadAB-monoassociated mice might be due to differences in
AMP susceptibility. Transcription of the cryptdin-4 gene (defa4) and
those of other AMPs in ileal tissue from NC101- and NC101gadAB-
monoassociated mice was similar, indicating that differences in lumi-
nal bacterial concentrations in the two groups of mice are not due to
differences in AMP gene expression (see Fig. S3 in the supplemental
material).
GadAB in luminal E. coli attenuate the development of ex-
perimental colitis. To determine whether the decreased luminal
bacterial concentrations of gadAB-expressing NC101 correlate
with decreased colitis, we monoassociated WT and IL-10/ mice
with E. coli NC101 and NC101gadAB for 2, 5, and 10 weeks and
quantified colonic inflammation using a validated blinded histo-
logical scoring system described previously (8). As expected, IL-
10/ mice colonized with NC101 exhibited increased histologi-
cal inflammation compared to WT mice at 5 and 10 weeks (Fig. 3A
and B). Consistent with the increased luminal concentrations of
NC101gadAB compared to those of NC101, histological inflam-
mation scores in NC101gadAB monoassociated IL-10/ and
WT mice were higher than those in NC101-monoassociated mice
(Fig. 3A and B).
The activation of innate immune pathways, including IL-12
and IL-23 secretion, is associated with experimental colitis and
human IBDs (8, 27). We therefore tested whether the expression
of gadAB in luminal E. coli isolates of monoassociated mice affects
the secretion of IL-12/23p40 by colon explants. In accordance
with decreased colonic histological inflammation, spontaneous
secretion of IL-12/23p40 was lower in colon explants from IL-
10/ mice monoassociated with NC101 for 2 and 5 weeks and
WT mice monoassociated with NC101 for 5 and 10 weeks than the
corresponding NC101gadAB-monoassociated mice (Fig. 3C).
Using multiplex immunoassays, we also detected increased levels
of the proinflammatory cytokines IFN-, IL-6, IL-17, and TNF-
in cultures of colon explants from IL-10/ mice monoassociated
with NC101gadAB for 5 weeks compared to those in cultures of
colon explants from NC101-monoassociated IL-10/ mice
(Fig. 3D).
Because IL-12 and IL-23 promote the clonal expansion of IFN-
-producing Th1 and IL-17-producing Th17 cells, respectively,
both of which play a crucial role in the development of chronic-
immune mediated colitis (28), we next aimed to determine
whether the increased innate immune responses observed in mice
monoassociated with NC101gadAB were associated with en-
hanced antigen-specific adaptive immune responses. Therefore,
we measured IFN- secretion by NC101 lysate-stimulated MLN
cells isolated from NC101- or NC101gadAB-monoassociated
WT and IL-10/ mice. Consistent with the increased levels of
proinflammatory cytokines in cultures of colon explants from
NC101gadAB-monoassociated mice, stimulated MLN cells from
both WT and IL-10/ mice colonized with NC101gadAB pro-
duced significantly more IFN- than MLN cells from mice monoas-
sociated with NC101 (Fig. 3E). MLN cells isolated from NC101- and
NC101gadAB-monoassociated mice and stimulated with lysate
from the unrelated bacterium Enterococcus faecalis secreted similar
and very small amounts of IFN- (data not shown).
To confirm that the increased inflammatory responses in
NC101gadAB-monoassociated IL-10/ mice were due to the
absence of glutamate decarboxylase function and not an artifact of
creating the deletion mutant, we repeated monoassociation stud-
ies using a strain of NC101gadAB in which gadB was expressed
from a stable episome [NC101gadAB(pgadB)]. Luminal bacte-
rial concentrations, histological scores, and spontaneous IL-12/
23p40 secretion by colon explants from IL-10/ mice monoas-
sociated with NC101gadAB(pgadB) for 2 and 5 weeks were not
different from those for NC101-monoassociated IL-10/ mice
(Fig. 4), confirming that glutamate decarboxylase activity in
NC101 is responsible for the observed attenuated colitis pheno-
FIG 2 GadAB inhibits luminal E. coli survival and enhances cryptdin-4-me-
diated killing in vitro. (A) Cecal bacterial concentrations in monoassociated
WT and IL-10/ mice. Data are presented as mean  SEM (n  5 mice per
group). *, P  0.05 relative to mice with the same genetic background mono-
associated with NC101. (B) NC101 and NC101gadAB growth curves under
aerobic or anaerobic conditions. Data are presented as the mean  SEM (n 
2 separate cultures/strain). OD600, optical density at 600 nm. (C) Killing curves
of mid-log-phase NC101, NC101gadAB, and complemented NC101gadAB
(NC101gadAB attTn7::gadBA) bacteria treated with recombinant mouse
cryptdin-4. Data show the percentage of surviving bacteria relative to the num-
bers of untreated controls, presented as the mean  SD of three separate
experiments. *, P  0.05 relative to NC101gadAB.
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type. Overall, these data indicate that expression of gadAB in lu-
minal E. coli isolates is associated with reduced colonic inflamma-
tion and decreased mucosal innate and adaptive immune
responses in monoassociated IL-10/ mice.
Since results obtained using monoassociated mice may not ac-
curately represent those observed in mice with a complex intesti-
nal microbiota, we colonized WT and IL-10/ mice with a mix-
ture of seven commensal strains representative of the normal gut
microbiota, together with either E. coli NC101 or NC101gadAB,
for 5 and 10 weeks (octoassociation). We found significantly in-
creased expression of gadA and gadB in luminal E. coli isolates
from octoassociated IL-10/ mice at 10 weeks (Fig. 5A and B).
Similar to results obtained in monoassociated IL-10/ mice, lu-
minal E. coli densities, histological inflammation scores, and
spontaneous IL-12/23p40 secretion by colon explants from IL-
10/ mice colonized with a complex bacterial mixture that in-
cluded NC101gadAB were significantly increased compared to
those for mice colonized with a complex bacterial mixture that
included NC101 at 5 weeks (Fig. 5C to E). These results suggest
that expression of gadAB in luminal E. coli NC101 attenuates coli-
tis even in the presence of a complex microbiota.
Expression of gadAB decreases translocation of E. coli across
intestinal epithelial cells. Since our initial observations indicated
that gadAB expression is associated with reduced colonic inflam-
FIG 3 The presence of E. coli gadAB is associated with attenuated host proinflammatory immune responses in NC101-monoassociated IL-10/ and WT mice.
(A) Composite blinded histological inflammation scores of colonic segments from IL-10/ or WT mice monoassociated for the indicated times. (B) Repre-
sentative photomicrographs of cecum from WT and IL-10/ mice monoassociated for 5 weeks, as described in panel A. Magnifications, 20. KO, knockout.
(C) Spontaneous secretion of IL-12/23p40 in culture supernatants from proximal colon explants measured by ELISA. (D) Proinflammatory cytokine levels in
colon explant cultures from IL-10/ mice monoassociated with NC101gadAB for 5 weeks relative to those in mice monoassociated with NC101 measured by
multiplex immunoassays. MCP-1, monocyte chemoattractant protein 1. (E) IFN- secretion by unfractionated MLN cells stimulated ex vivo with E. coli NC101
lysate. Data are presented as the mean  SEM (n  5 to 6 mice per group for all panels except panel D, for which 4 mice were used per group). *, P  0.05 relative
to NC101-monoassociated mice of the same genetic background.
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mation and decreased mucosal immune responses to NC101 and
because access to lamina propria antigen-presenting cells is nec-
essary for bacteria to stimulate antigen-specific immune re-
sponses, we examined whether decreased colitis in NC101-mono-
associated IL-10/ mice corresponds to a reduced ability of E.
coli NC101 to adhere to the intestinal epithelium compared with
that for NC101gadAB. We determined the densities of epithelial
cell-associated E. coli in intestinal fragments from IL-10/ mice
monoassociated with NC101 and NC101gadAB for 2, 5, and 10
weeks using fluorescence microscopy. Semiquantitative analysis
of anti-E. coli antibody-stained intestinal sections revealed signif-
icantly increased numbers of luminal bacteria adjacent to the in-
testinal epithelium in NC101-monoassociated IL-10/ mice
compared to NC101gadAB-monoassociated IL-10/ mice at 2
weeks but a less pronounced increase at 5 weeks (P  0.06) (Fig.
6A). To confirm these results, we measured the relative levels of
the E. coli 16S rRNA gene copies on extensively washed cecal tissue
from monoassociated IL-10/ mice using quantitative PCR. We
detected significantly more E. coli 16S rRNA gene copies on cecal
tissue from IL-10/ mice monoassociated with NC101 than IL-
10/ mice monoassociated with NC101gadAB for 2 and 5
weeks (Fig. 6B). Though the difference was not statistically signif-
icant, numerically more E. coli 16S rRNA gene copies and anti-
body-stained E. coli cells were detected on intestinal tissue from
NC101-monoassociated mice than NC101gadAB-monoassoci-
ated mice at 10 weeks (Fig. 6A and B). These results indicate that
expression of gadAB in NC101 is associated with increased num-
bers of colonic epithelial cell surface-associated E. coli soon after
colonization and are counter to our hypothesis that the attenuated
colitis observed in NC101-monoassociated mice compared to that
observed in NC101gadAB-monoassociated mice correlates with
decreased numbers of epithelial cell-associated bacteria.
Based on these unexpected results, we postulated that NC101
cells accumulate at the epithelial surface because of decreased bac-
terial translocation to the lamina propria and therefore cause less
colitis than NC101gadAB cells. To test this hypothesis, we
infected polarized T84 intestinal epithelial cell monolayers in
transwells with NC101 and NC101gadAB under transloca-
tion-permissive (37°C) and -nonpermissive (4°C) conditions
and determined the numbers of epithelial cell-associated and
translocated E. coli cells using culture plating. Similar to the in
vivo results, we detected significantly more NC101 bacteria
than NC101gadAB bacteria associated with T84 cells after infec-
tion at the translocation-permissive temperature of 37°C (Fig.
7A). However, there was no significant difference in the numbers
of epithelial cell-associated bacteria between the two strains after
infection at the translocation-nonpermissive temperature of 4°C
(Fig. 7A). In addition, confocal imaging of infected polarized T84
monolayers in transwells at 37°C also showed higher densities of
NC101 bacteria than NC101gadAB bacteria on the epithelial
surface (Fig. 7B). These data indicate that NC101gadAB may
translocate across epithelial cell monolayers more efficiently than
NC101.
To confirm that expression of gadAB in NC101 impairs E. coli
translocation across epithelial cells in vitro, we directly measured
the numbers of NC101 and NC101gadAB bacteria that migrated
to the basolateral compartment of polarized T84 cell monolayers
at 37°C and found significantly fewer NC101 than NC101gadAB
bacteria at all time points investigated (Fig. 7C). Complementa-
tion of NC101gadAB with gadAB partially restored the translo-
cation phenotype to that observed for NC101 at 8 and 10 h (see
Fig. S4 in the supplemental material). In addition, we detected
fewer intracellular bacteria in polarized T84 cells infected with
NC101 at 37°C than cells infected with NC101gadAB (Fig. 7D).
These data suggest that gadAB expression reduces the ability of
NC101 to enter, survive within, and/or exit intestinal epithelial
FIG 4 Complementation of NC101gadAB restores the E. coli NC101 phe-
notype in IL-10/ monoassociated mice. (A) Luminal bacterial concentra-
tions in the cecum; (B) composite blinded histological inflammation scores of
colonic segments; (C) spontaneous secretion of IL-12/23p40 in culture super-
natants from proximal colon explants of IL-10/ mice monoassociated with
NC101 or complemented NC101gadAB [NC101gadAB(pgadB)] for the in-
dicated times. Data are presented as the mean  SEM (n  6 mice per group).
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cells in vitro. Together, the results of these in vitro experiments
indicate that E. coli gadAB expression inhibits translocation across
intestinal epithelial cells, resulting in increased numbers of apical
epithelial cell-associated bacteria and may explain how these in-
flammation-induced bacterial genes attenuate colitis in vivo.
DISCUSSION
While the importance of the commensal enteric microbiota, in-
cluding E. coli, in the development of IBDs and experimental coli-
tis has previously been established, the mechanisms by which the
host inflammatory responses influence the intestinal bacteria are
still poorly understood. We reported in a previous study that E.
coli bacterial stress response genes, including gadAB, are highly
upregulated in IL-10/ mice with a long-term bacterial mono-
association (14). We show here that the increased expression of
gadAB in luminal E. coli NC101 from IL-10/ mice coincides
with advanced histological intestinal inflammation at 10 weeks.
Unexpectedly however, gadAB expression is also elevated in E.
coli isolates from WT mice at early time points, suggesting that
factors unrelated to histological inflammation also upregulate
gadAB. Although the mechanisms involved in the early upregula-
tion of gadAB in WT mice remain to be determined, innate im-
mune responses might be suspected due to the early timing. Al-
ternatively, IL-10 produced by intestinal tissue during early phases
of bacterial colonization could directly upregulate E. coli gadAB.
However, addition of recombinant IL-10 to E. coli cultures in vitro
had no effect on gadAB expression (data not shown). Whatever
the cause, it is tempting to speculate that early expression of gadAB
in luminal E. coli isolates in WT mice may facilitate intestinal
homeostasis, since WT mice monoassociated with NC101gadAB
had increased proinflammatory immune responses at later time
points (Fig. 3).
The mechanisms responsible for later inflammation-associ-
ated expression of gadAB are equally enigmatic. While stationary-
phase growth, osmotic shock, norepinephrine, indole, and so-
dium have all been implicated as potential regulators of gadAB
FIG 5 Presence of E. coli gadAB is associated with attenuated host proinflammatory immune responses in octoassociated IL-10/ and WT mice. Expression of
gadA (A) and gadB (B) in cecal E. coli from octoassociated mice. (C) Number of E. coli genomes per ng cecal content DNA. (D and E) Composite blinded
histological inflammation scores of colonic segments (D) and spontaneous secretion of IL-12/23p40 in culture supernatants from proximal colon explants (E)
of WT and IL-10/ mice octoassociated for 5 weeks with 7 bacteria and either NC101 or NC101gadAB. Data are presented as the mean  SEM (n  5 mice
per group). *, P  0.05 relative to WT mice (A and B) or relative to octoassociated and NC101-monoassociated mice of the same genetic background (C to E).
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expression (17, 29–31), none of these factors have been reported
to be increased in the lumen during colitis. Most of the published
data support a role for gadAB in acid tolerance (16). While others
have reported decreased luminal pH during colitis (18), we found
no significant differences in pH or glutamine or glutamate levels
in cecal contents from IL-10/ mice with colitis versus WT con-
trols (data not shown). Therefore, factors other than low pH and
glutamate/glutamine levels are likely stimulating expression of E.
coli gadAB in this model system. Interestingly, others have dem-
onstrated that gadB expression is regulated by oxyS, a small regu-
latory RNA which is important in E. coli stress responses to oxi-
dative environments, such as the oxidative environment found in
the inflamed intestine, and which is also upregulated in luminal E.
coli isolates from colitic mice (14, 32, 33). Therefore, we speculate
that inflammation-associated upregulation of E. coli gadAB may
be caused by oxidative stress rather than acidic pH.
Contrary to our initial hypothesis, gadAB expression decreases
survival of E. coli NC101 in the inflamed intestine and is associated
with reduced innate and adaptive immune responses and attenu-
ated colitis. We provide in vitro evidence that one reason for the
decreased luminal concentrations of gadAB-expressing E. coli may
be an increased susceptibility to killing by the mouse AMP crypt-
din-4. How gadAB expression enhances the susceptibility of E. coli
to AMP killing and whether this phenomenon occurs in vivo re-
main to be determined. However, since gadAB helps maintain a
normal proton motive force across the bacterial inner membrane,
which may be necessary for cryptdin-4-mediated killing (24–26),
we propose that the proton-exporting function of the GadAB sys-
tem mediates this effect.
Due to the intestinal epithelial barrier that separates potentially
proinflammatory microbes from the mucosal immune system,
luminal bacterial concentrations do not necessarily correlate with
colitis. Translocation of the commensal microbiota or microbial
products across the epithelium is required for host immune acti-
vation. We show that E. coli GadAB inhibits bacterial transloca-
tion in polarized colonic epithelial cell cultures, but the mecha-
nism is unclear. Others have reported that activation of the PhoB
regulon is associated with decreased adherence of pathogenic E.
coli to intestinal epithelial cells (34). Since PhoB also regulates acid
stress responses (35), it is conceivable that GadAB-mediated inhi-
bition of E. coli translocation is also PhoB dependent. However,
regulation of gadAB by PhoB has not yet been reported.
We therefore propose a model in which gadAB expression in
luminal E. coli increases susceptibility to killing by antimicrobial
peptides and decreases migration across the epithelium, which
reduces the density of priming microbes in the lamina propria and
diminishes host inflammatory responses.
The reason why E. coli would upregulate a gene that ultimately
proves to be detrimental to its survival in the colon is still unclear.
However, we and others have observed similar findings with dif-
ferent stress response genes (14, 36). It might be more important
for commensal E. coli to dampen inflammation triggered by any
gut microbe rather than to develop mechanisms to overcome host
immune responses. Indeed, others have shown that enterohemor-
rhagic E. coli suppresses host inflammatory responses to its own
toxin (37). In addition, the paradox could be explained by limita-
tions of our experimental system, since selective colonization does
not accurately reflect the natural gut environment, where many
other commensal microbes are present. These commensals may
not only contribute to the inflammatory responses but also poten-
tially interact with E. coli and affect its gene expression. However,
we demonstrate that gadAB expression has a detrimental effect on
E. coli survival and its colitogenic potential even in the presence of
a more complex microbiota (Fig. 5). Moreover, others have also
reported that E. coli lacking gadX and gadW genes that regulate
expression of gadAB outcompete parental E. coli MG1655 in the
streptomycin-treated mouse intestine, which harbors a complex
microbiota (38). Interestingly, colitis is not associated with signif-
icant upregulation of gadB in cecal E. coli strain LF82 from IL-
10/ mice colonized with a complex defined microbiota relative
to its expression in WT controls, suggesting that E. coli transcrip-
tional responses to inflammation are not shared by all E. coli
strains (data not shown). Lastly, it is possible that mucosa-associ-
ated bacteria that are closer to epithelial and immune cells exhibit
gene expression profiles that are different from those of most lu-
minal bacteria. Further studies that dissect the effects of different
host cells on bacterial transcription will extend the biological rel-
evance of our findings.
In summary, we have shown that expression of the bacterial
stress response genes gadAB is differentially regulated in commen-
sal luminal E. coli isolates from mice with colitis than healthy
FIG 6 The presence of E. coli gadAB is associated with increased numbers of
bacteria at the apical surface of intestinal epithelial cells in vivo. (A) Numbers
of apical epithelial cell-associated bacteria in 18 20-magnification fields
of intestinal tissue per IL-10/ mouse monoassociated with NC101 or
NC101gadAB. (B) Relative numbers of E. coli 16S DNA copies in washed
cecal tissue from the same IL-10/ mice used for the experiment whose re-
sults are shown in panel A. Results are normalized to the level of tissue GAPDH
expression. Data are presented as the mean  SEM (n  5 mice per group). *,
P  0.05 relative to NC101gadAB-monoassociated mice; **, P  0.01 relative
to NC101gadAB-monoassociated mice.
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controls. Furthermore, gadAB expression is associated with de-
creased luminal bacterial survival and reduced host inflammatory
responses in vivo as well as increased sensitivity to the -defensin
cryptdin-4 and an impaired ability to migrate across intestinal
epithelial cells. These studies provide evidence that host intestinal
inflammation affects commensal microbial function in a manner
that reduces inflammation. An enhanced understanding of the
mechanisms by which inflammation controls bacterial gene ex-
pression and how inflammation-induced bacterial stress re-
sponses impact chronic immune-mediated colitis will improve
our knowledge of the pathogenesis of IBDs and could lead to the
development of novel therapies that target the host-microbe dia-
logue.
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